MIRA INFORM REPORT

 

 

Report No. :

326993

Report Date :

16.06.2015

 

IDENTIFICATION DETAILS

 

Name :

ATRA PHARMACEUTICALS LIMITED (w.e.f 04.06.2014)

 

 

Formerly Known As :

FULLERTON INDIA CREDIT COMPANY LIMITED

 

 

Registered Office :

Anjali Complex, Khadkeshwar, Aurangabad – 431 001, Maharashtra 

Tel. No.:

91-240-6609999

 

 

Country :

India

 

 

Financials (as on) :

31.03.2014

 

 

Date of Incorporation :

01.10.1991

 

 

Com. Reg. No.:

11-063442

 

 

Capital Investment / Paid-up Capital :

Rs.96.435 Million

 

 

CIN No.:

[Company Identification No.]

U24230MH1991PLC063442

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

PAN No.:

[Permanent Account No.]

AABCA5523A

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Manufacturer of Ayurvedic and Allopathic, Drug

 

 

No. of Employees :

200 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (26)

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Maximum Credit Limit :

USD 490000

 

 

Status :

Moderate

 

 

Payment Behaviour :

Slow but correct

 

 

Litigation :

Exist

 

 

Comments :

Subject is an established company having moderate track record.

 

The rating is constrained on account of company’s weak financial risk profile marked by modest scale of operations, volatile operating margins, leveraged capital structure with weak debt coverage indicators and net loss in FY14.

 

However, trade relations are fair. Business is active. Payments are reported to be slow but correct.

 

The company can be considered for business dealing with some caution.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – March 31, 2015

 

Country Name

Previous Rating

(31.12.2014)

Current Rating

(31.03.2015)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

EXTERNAL AGENCY RATING

 

 

Rating Agency Name

CARE

Rating

Long Term Bank facilities B+

Rating Explanation

Risk-prone-credit-quality and carries very high credit risk.

Date

March 02, 2015

 

Rating Agency Name

CARE

Rating

Short Term Bank facilities A4

Rating Explanation

Minimal degree of safety and very high credit risk

Date

March 02, 2015

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2013.

 

 

INFORMATION PARTED BY (GENERAL DETAILS)

 

Name :

Mr. Thomas

Designation :

Admin

Contact No.:

91-240-6609999

Date :

13.06.2015

 

 

LOCATIONS

 

Registered Office / Head Office :

Anjali Complex, Khadkeshwar, Aurangabad – 431 001, Maharashtra, India  

Tel. No.:

91-240-6609999 / 2332211

Fax No.:

91-240-6609990/ 2331515

E-Mail :

info@atrapharma.com

atra99@hotmail.com

atra_pharma@yahoo.co.in

cs@atrapharma.com

Website :

http://www.atrapharma.com

 

 

Factory 1 :

H-19, M.I.D.C., Waluj, Aurangabad – 431 133, Maharashtra, India

Tel. No.:

91-240-6603311/ 6603322

Fax No.:

91-240-6603366

E-Mail :

works@atrapharma.com

 

 

Factory 2 :

H-12 and 13, M.I.D.C., Waluj, Aurangabad – 431 136, Maharashtra, India

Tel No.:

91-240-6603340/ 6603341

Fax No.:

91-240-6609900

E-Mail :

unit-ii@atrapharma.com

 

 

Mumbai Office :

D-402, Krishna Galaxy, Datta Mandir Road, Vakola, Santacruz (East), Mumbai – 400 055, Maharashtra, India

Tel. No.:

91-22-26680072/ 26682059

Fax No.:

91-22-26682059

E-Mail :

narendra-tembe@atrapharma.com

atra@vsnl.com

 

 

DIRECTORS

 

As on 30.09.2014

 

Name :

Crd. Anil Moreshwar Save (Retd.)

Designation :

Managing Director

Address :

“Anjali Complex”, Khadkeshwar, Aurangabad – 431 001, Maharashtra, India

Date of Birth/Age :

13.05.1953

Qualification :

Graduate

Date of Appointment :

01.10.1991

DIN No.:

00561935

PAN No.:

ACZPS0141H

 

 

Name :

Mr. Atul Moreshwar Save

Designation :

Director

Address :

“Anjali Complex”, Khadkeshwar, Aurangabad – 431 001, Maharashtra, India

Date of Birth/Age :

26.02.1962

Qualification :

Graduate

Date of Appointment :

01.10.1991

DIN No.:

00562021

PAN No.:

ACHPS7762G

 

 

Name :

Dr. Rajeev Yadav Churi

Designation :

Director

Address :

Flat No.9, Moon Stone Apartment, 65-E, Linking Road, Santacruz (West), Mumbai, Maharashtra, India

Date of Birth/Age :

10.12.1956

Date of Appointment :

01.10.1991

DIN No.:

00561987

PAN No.:

AAAPC8651R

 

 

Name :

Mrs. Anjali Deepak Raut

Designation :

Director

Address :

“Jamuna”, Triveni Co-Operative Housing Society, Navghar, Bassein Road, Thane (West), Maharashtra, India

Date of Birth/Age :

22.06.1969

Qualification :

Graduate

Date of Appointment :

01.12.1995

DIN No.:

01188379

 

 

Name :

Mr. Ajit Moreshwar Save

Designation :

Director

Address :

“Anjali Complex”, Khadkeshwar, Aurangabad – 431 001, Maharashtra, India

Date of Birth/Age :

19.02.1956

Qualification :

Graduate

Date of Appointment :

01.12.1995

DIN No.:

00561875

PAN No.:

ADCPS0196G

 

 

Name :

Mr. Deepak Hari Raut

Designation :

Director

Address :

“Jamuna”, Triveni Co-Operative Housing Society, Navghar, Bassein Road, Thane (West), Maharashtra, India

Date of Birth/Age :

12.10.1950

Qualification :

Graduate

Date of Appointment :

01.12.1995

DIN No.:

01239598

 

 

Name :

Mr. Arpit Anil Save

Designation :

Whole Time Director

Address :

“Anjali Complex”, Khadkeshwar, Aurangabad – 431 001, Maharashtra, India

Date of Birth/Age :

10.08.1987

Qualification :

Graduate

Date of Appointment :

01.04.2010

DIN No.:

02863344

PAN No.:

BZHPS2309P

 

 

KEY EXECUTIVES

 

Name :

Mr. Thomas

Designation :

Admin

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on : 30.09.2014

 

Names of Shareholders

 

No. of Shares

Save Moreshwar Anil

 

2323688

Save Moreshwar Atul

 

104835

Save Moreshwar Ajit

 

550485

Save Dinanath Moreshwar

 

870000

Save Moreshwar Leelawati

 

480000

Save Atul Anjali

 

842700

Save Ajit Minal

 

316275

Save Anil Anjali

 

697500

Save Atul Ajinkya

 

56100

Save Ajit Ameya

 

53400

Save Ajit Anmol

 

53400

Save Atul Anurag

 

56100

Save Anil Arpit

 

570000

Save Anil Awanti

 

292050

Chruri Yadav Rajeev

 

802110

Raut Deepak Anish

 

11250

Churi Rajeev Chaitanya

 

35288

Raut Hari Deepak

 

15000

Gill Ajmersingh Gurudishsingh

 

547561

Bagga S. A.

 

6000

Chaudhari Bhavanishankar Narendra

 

            2250

Patil Kushaba Narayan

 

32250

Raut Deepak Anjali

 

15000

Churi Rajeev Cherry

 

22500

Gill Gurudishsingh Sukdeepkaur

 

196275

Arun C. Bari

 

18750

Neelam Arora

 

37500

Anjali Cinetorium Private Limited, Maharashtra,

 

33000

Savera Carriers & Contractors Private Limited, Maharshtra

 

11250

Savera Computers

 

356088

Thomas Omen

 

18750

Shweta Laxman Patil

 

3750

Shripat Laxmikant Deshpande

 

3750

Shivaji Jagannath Vispute

 

3750

Sunil Sambhaji Mohalkar

 

3750

V. R. Prman

 

7500

Arun Mandle

 

7500

Total

 

9457355

 

As on 23.07.2014

 

Names of Shareholders

 

No. of Shares

Gurudish Ajmersingh Singh Gill

 

84175

Avanti Anil Save

 

84175

Total

 

168350

 

As on 11.11.2014

 

Names of Shareholders

 

No. of Shares

Avanti Anil Save

 

17845

Total

 

17845

 

 

Equity Share Break up (Percentage of Total Equity)

 

As on 30.09.2014

 

Category

Percentage

Bodies corporate

0.47

Directors or relatives of Directors

83.28

Other top fifty shareholders

16.25

Total

100.00

 

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Ayurvedic and Allopathic, Drug

 

 

Products :

Item Code No.

Product Description

9804

Drugs and Medicines

 

 

Brand Names :

Not Divulged

 

 

Agencies Held :

Not Divulged

 

 

Exports :

 

Countries :

Bangladesh

 

 

Imports :

 

Countries :

Germany

 

 

Terms :

 

Selling :

Cash and Cheque

 

 

Purchasing :

Cash and Cheque

 

 

PRODUCTION STATUS NOT AVAILABLE

 

 

GENERAL INFORMATION

 

Suppliers :

Reference :

Not Divulged

Name of the Person :

Not Divulged

Contact No.:

Not Divulged

Since How Long Known :

Not Divulged

Maximum Limit Dealt :

Not Divulged

Experience :

Not Divulged

Remark:

Not Divulged

 

 

Customers :

Reference :

Not Divulged

Name of the Person :

Not Divulged

Contact No.:

Not Divulged

Since How Long Known :

Not Divulged

Maximum Limit Dealt :

Not Divulged

Experience :

Not Divulged

Remark:

Not Divulged

 

 

No. of Employees :

200 (Approximately)

 

 

Bankers :

Bank Name

Panjab National Bank

Branch

Aurangabad – 431003, Maharashtra, India

Person Name (With Designation)

Not Divulged

Contact Number

Not Divulged

Name of Account Holder

Not Divulged

Account Number

Not Divulged

Account Since (Date/Year of Account Opening)

Not Divulged

Average Balance Maintained (If Possible)

Not Divulged

Credit Facilities Enjoyed (If any)

Not Divulged

Account Operation

Not Divulged

Remarks (If any)

Not Divulged

 

  • Kotak Mahindra Bank Limited, Nariman Point, Mumbai – 400021, Maharashtra, India
  • Vasai Vikas Sahakari Bank Limited, Head Office: Samaj Mandir, Opposite New English High School, Vasai – 401 201, Maharashtra, India
  • Jalgaon Janta Sahakari Bank Limited, Seva, 117/119, Navipath, Branch Aurangabad, Jalgaon – 425001, Maharashtra, India

 

 

Facilities :

Secured Loan

31.03.2014

(Rs. in Million)

31.03.2013

(Rs. in Million)

Long-term Borrowings

 

 

Rupee Term loan from Bank

235.631

256.330

(Personal guarantee of Mr. Anil Save, Mr. Ajit Save and Dr. Rajeev Chri)

 

 

 

 

 

Short-term borrowings

 

 

Loans Repayable on Demand from Bank

142.627

110.047

Total

378.258

366.377

 

Auditors :

 

Name :

Ashok Patil and Associates

Chartered Accountants

Address :

A.P. Heights, Behind Gopal Cultural Hall, New Osmanpura, Aurangabad – 431 005, Maharashtra, India

PAN N Income-tax PAN of auditor or auditor's firm :

ABFPP1555R

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Sister Concern :

Savera Pharmaceuticals

Address:

H – 39 and 40, MIDC Waluj, Aurangabad – 431133, Maharashtra, India

Tel No.:

91-240-6603361 / 62

Fax No.:

91-240-6603376

Email Id.:

ppc.savera@atrapharma.com

 

 

Other Related Parties :

  • Savera Auto Comps Private Limited, India

U29299MH1996PTC102506

 

  • Atra Biotech Private Limited

U24233MH2011PTC220740

 

  • Avanti Clinical Research Laboratories Private Limited, India

U85191MH2011PTC221487

 

 

Associates :

  • Savera Carriers And Contractors Private Limited, India

U63040MH1979PTC021382

 

 

CAPITAL STRUCTURE

 

As on 30.09.2014

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

10000000

Equity Shares

Rs.10/- each

Rs.100.000 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

9457355

Equity Shares

Rs.10/- each

Rs.94.573 Million

 

 

 

 

 

 

After As on 30.09.2014

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

10000000

Equity Shares

Rs.10/- each

Rs.100.000 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

9643550

Equity Shares

Rs.10/- each

Rs.96.436 Million

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

31.03.2014

31.03.2013

31.03.2012

 

 

 

 

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

94.573

88.494

58.996

(b) Reserves & Surplus

75.921

75.205

103.955

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

170.494

163.699

162.951

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

243.268

289.822

274.855

(b) Deferred tax liabilities (Net)

34.405

24.930

17.934

(c) Other long term liabilities

25.288

33.334

23.549

(d) long-term provisions

0.000

0.000

0.000

Total Non-current Liabilities (3)

302.961

348.086

316.338

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

142.627

110.047

68.068

(b) Trade payables

262.677

43.109

18.190

(c) Other current liabilities

70.761

54.086

2.217

(d) Short-term provisions

117.070

80.439

64.166

Total Current Liabilities (4)

593.135

287.681

152.641

 

 

 

 

TOTAL

1066.590

799.466

631.930

 

 

 

 

II.          ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

427.145

430.761

79.728

(ii) Intangible Assets

0.040

0.040

0.040

(iii) Capital work-in-progress

55.841

45.225

255.509

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.384

23.205

23.205

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

112.845

129.581

99.126

(e) Other Non-current assets

0.000

0.070

0.140

Total Non-Current Assets

596.255

628.882

457.748

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

155.598

74.473

44.505

(c) Trade receivables

189.926

20.099

14.241

(d) Cash and cash equivalents

(1.078)

0.561

31.439

(e) Short-term loans and advances

5.578

1.250

6.353

(f) Other current assets

120.311

74.201

77.644

Total Current Assets

470.335

170.584

174.182

 

 

 

 

TOTAL

1066.590

799.466

631.930

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2014

31.03.2013

31.03.2012

 

SALES

 

 

 

 

Revenue from Operations

384.806

132.961

117.302

 

Other Income

8.163

13.928

4.322

 

TOTAL (A)

392.969

146.889

121.624

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Cost of Materials Consumed

224.245

37.081

31.328

 

Exceptional Items

(5.047)

(0.124)

(0.669)

 

Employees benefits expense

52.246

35.712

33.174

 

Other expenses

38.592

36.832

38.870

 

TOTAL (B)

310.036

109.501

102.703

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (C)

82.933

37.388

18.921

 

 

 

 

 

Less

FINANCIAL EXPENSES (D)

53.753

9.504

1.451

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D) (E)

29.180

27.884

17.470

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION (F)

22.994

14.722

6.312

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX (E-F)   (G)

6.186

13.162

11.158

 

 

 

 

 

Less

TAX (H)

8.509

7.270

3.380

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX  (G-H)   (I)

(2.323)

5.892

7.778

 

 

 

 

 

 

Earnings / (Loss) Per Share (Rs.)

0.00

1.00

1.32

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

Particulars

 

31.03.2014

31.03.2013

31.03.2012

Current Maturities of Long term debt

54.504

40.488

0.000

Cash generated from operations

NA

NA

NA

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2014

31.03.2013

31.03.2012

Net Profit Margin

(PAT / Sales)

(%)

(0.60)

4.43

6.63

 

 

 

 

 

Operating Profit Margin

(PBIDT/Sales)

(%)

21.55

28.12

16.13

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

0.61

1.80

3.16

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.04

0.08

0.07

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

2.26

2.44

2.10

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

0.79

0.59

1.14

 

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Share Capital

58.996

88.494

94.573

Reserves & Surplus

103.955

75.205

75.921

Net worth

162.951

163.699

170.494

 

 

 

 

long-term borrowings

274.855

289.822

243.268

Short term borrowings

68.068

110.047

142.627

Current Maturities of Long-Term Debts

0.000

40.488

54.504

Total borrowings

342.923

440.357

440.399

Debt/Equity ratio

2.104

2.690

2.583

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

117.302

132.961

384.806

 

 

13.349

189.413

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

117.302

132.961

384.806

Profit / (Loss)

7.778

5.892

(2.323)

 

6.63%

4.43%

(0.60%)

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report (Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

No

5

Buyer visit details

--

6

Contact numbers

Yes

7

Name of the person contacted

Yes

8

Designation of contact person

Yes

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

Yes

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

Yes

16

No. of employees

Yes

17

Details of sister concerns

Yes

18

Major suppliers

No

19

Major customers

No

20

Banking Details

Yes

21

Banking facility details

Yes

22

Conduct of the banking account

--

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

Yes

26

Turnover of firm for last three years

Yes

27

Reasons for variation <> 20%

--

28

Estimation for coming financial year

No

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

Yes

32

Litigations that the firm/promoter involved in

Yes

33

Market information

--

34

Payments terms

Yes

35

Negative Reporting by Auditors in the Annual Report

No

 

 

 

 

PERFORMANCE

 

During the year under consideration, company has achieved a gross turnover of Rs. 579.047 Million as compared to the gross turnover of Rs. 317.903 Million of last year. It has earned net profit before tax of Rs. 6.186 Million during this year as compared to net profit of Rs. 13.038 Million of preceding year. No doubt we have achieved good results for FY 2013-14, but we believe we are poised to achieve organic as well as inorganic growth in the years. In the coming years we intend to concentrate more on our own domestic sales which is presently restricted to four states of Andhra Pradesh, Gujarat, Madhya Pradesh and Chhattisgarh. We plan to appoint franchisee distributors Pan India for our generic product range. Besides our own sales in domestic market, we wish to focus on niche products in the Allopathic, Ayurvedic and Veterinary range for exports to Rest of the World Market, while trying to register our products from our new plant in the regulated Markets like Australia, South Africa, Europe and subsequently USA etc. The company has also aggressively started preparing dossiers and soon intends to file for Market Authorization in various countries. We are also working for patent filing and hope to file at least two patents in the next year. The company despite having sold one of its manufacturing unit in the previous year has been able to maintain the production output by various steps taken to improve productivity and optimal utilization of plant and machinery. The table below would highlight the performance of the company in absolute terms.

 

 

UNSECURED LOAN

 

Unsecured Loan

31.03.2014

(Rs. in Million)

31.03.2013

(Rs. in Million)

Long-term Borrowings

 

 

Deferred Payment liability

7.637

9.179

Loan and Advance from Directors

0.000

4.932

Loan and Advance from Others

0.000

19.381

Total

7.637

33.492

 

 

CASE DETAILS

 

Bench : Bombay

 

Presentation Date :23/04/2015

 

Lodging    CPL/365/2015         Filing          23/04/2015

No.:                                         Date :

Petitioner

NOBLE PRINTING PRESS -

 

 

 

 

 

Petn.Adv.:

M/S. DHRUVE LILADHAR AND COMPANY (151)

Respondent :

ATRA PHARMACEUTICALS LIMITED. CIN O.:

District :

MUMBAI

 

 

 

 

 

 

 

Bench :               SINGLE                                                      Category : COMPANY PETITION U/SEC

Status :               Pre-Admission                                                             433,434,439 COMPANIES ACT

Last Date :         30.04.2015

Last Coram :      REGISTRAR(OS)/PROTHONOTARY

Act :                    Companies Act and Rules 1956                    Under          433, 434 439

                                                                                             Section :

 

 

INDEX OF CHARGES

 

S.No.

Charge ID

Date of Charge Creation/Modification

Charge amount secured

Charge Holder

Address

Service Request Number (SRN)

1

10496860

19/04/2014

37,000,000.00

FULLERTON INDIA CREDIT COMPANY LIMITED

Megh Towers, Third Floor, Old No-307,, New No-165 
, Poonamallee High Road, Maduravoyal,, Chennai, Tamil Nadu - 600095, INDIA

C05214671

2

10465096

19/10/2013

3,600,000.00

VASAI VIKAS SAHAKARI BANK LTD

Head Office : Samaj Mandir, Opp. New English High 
School, Vasai, Maharashtra - 401201, INDIA

B91524496

3

10414956

30/03/2013

3,900,000.00

ELECTRONICA FINANCE LIMITED

128/A, Plot No.3,Kailashchandra Appartments,, Pau 
d Road, Kothrud, Pune, Maharashtra - 411038, INDIA

B71809198

4

10406953

28/02/2013

39,279,245.00

ELECTRONICA FINANCE LIMITED

128/A, Plot No.3,Kailashchandra Appartments,, Pau 
d Road, Kothrud, Pune, Maharashtra - 411038, INDIA

B69152098

5

10299049

03/08/2011

26,900,000.00

KOTAK MAHINDRA BANK LIMITED

36-38A, NARIMAN BHAVAN, 227,D,, NARIMAN POINT,, M 
UMBAI, Maharashtra - 400021, INDIA

B17621061

6

10295465

22/05/2013 *

483,700,000.00

Punjab National Bank

B/O Plot 316,, N-3, CIDCO, Aurangabad, Maharashtra - 431003, INDIA

B77370294

 

 

 

 

FIXED ASSETS

 

  • Land
  • Buildings
  • Factory building
  • Plant and equipment
  • Factory equipments
  • Vehicles
  • Motor vehicles
  • Office equipment
  • Computer equipments
  • Books periodicals

 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.64.04

UK Pound

1

Rs.99.57

Euro

1

Rs.71.84

 

 

INFORMATION DETAILS

 

Information Gathered by :

MNJ

 

 

Analysis Done by :

KAR

 

 

Report Prepared by :

SUJ


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

4

PAID-UP CAPITAL

1~10

3

OPERATING SCALE

1~10

4

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

3

--PROFITABILITY

1~10

--

--LIQUIDITY

1~10

3

--LEVERAGE

1~10

3

--RESERVES

1~10

3

--CREDIT LINES

1~10

3

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

YES

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

26

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.